Total Payments
$35,923
2022 Payments
$7,153
Companies
7
Transactions
39
Medicare Patients
434
Medicare Billing
$37,342
Payment Breakdown by Category
Other$32,400 (90.2%)
Consulting$2,000 (5.6%)
Food & Beverage$885.36 (2.5%)
Travel$637.62 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,400 | 15 | 90.2% |
| Consulting Fee | $2,000 | 1 | 5.6% |
| Food and Beverage | $885.36 | 19 | 2.5% |
| Travel and Lodging | $637.62 | 4 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $25,961 | 19 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $9,853 | 12 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31.40 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $25.86 | 2 | $0 (2017) |
| Mallinckrodt LLC | $22.39 | 2 | $0 (2017) |
| Pinnacle Biologics, Inc | $17.28 | 1 | $0 (2017) |
| Amgen Inc. | $11.66 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $7,153 | 8 | AstraZeneca Pharmaceuticals LP ($7,153) |
| 2020 | $2,576 | 3 | AstraZeneca Pharmaceuticals LP ($2,576) |
| 2019 | $17.25 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17.25) |
| 2018 | $11,085 | 8 | PFIZER INC. ($10,961) |
| 2017 | $15,091 | 19 | PFIZER INC. ($15,000) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Respiratory | ||||||
| 05/02/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Respiratory | ||||||
| 03/17/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $282.68 | General |
| Category: Respiratory | ||||||
| 03/17/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $114.66 | General |
| Category: Respiratory | ||||||
| 03/17/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $82.55 | General |
| Category: Respiratory | ||||||
| 03/10/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $116.63 | General |
| Category: Respiratory | ||||||
| 02/22/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $99.12 | General |
| Category: Respiratory | ||||||
| 02/02/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: Respiratory | ||||||
| 12/02/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| Category: Respiratory | ||||||
| 10/29/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $126.24 | General |
| Category: Respiratory | ||||||
| 09/06/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Respiratory | ||||||
| 11/21/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: RESPIRATORY | ||||||
| 07/09/2018 | PFIZER INC. | CHANTIX (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/07/2018 | PFIZER INC. | CHANTIX (Drug) | Travel and Lodging | In-kind items and services | $119.90 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/04/2018 | PFIZER INC. | CHANTIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/02/2018 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $91.23 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/11/2018 | PFIZER INC. | CHANTIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/28/2018 | PFIZER INC. | CHANTIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/28/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $124.21 | General |
| Category: Respiratory | ||||||
| 02/05/2018 | PFIZER INC. | CHANTIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/10/2017 | PFIZER INC. | CHANTIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/16/2017 | PFIZER INC. | CHANTIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/06/2017 | PFIZER INC. | CHANTIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/05/2017 | PFIZER INC. | CHANTIX (Drug) | Travel and Lodging | In-kind items and services | $120.38 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/04/2017 | PFIZER INC. | CHANTIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 65 | 74 | $19,280 | $5,174 |
| 2022 | 3 | 135 | 172 | $43,897 | $13,028 |
| 2021 | 3 | 128 | 154 | $38,740 | $12,265 |
| 2020 | 3 | 106 | 120 | $29,807 | $6,875 |
Total Patients
434
Total Services
520
Medicare Billing
$37,342
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 50 | 59 | $13,865 | $3,949 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $5,415 | $1,225 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 80 | 116 | $27,500 | $8,455 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 37 | 37 | $13,357 | $3,795 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 18 | 19 | $3,040 | $778.47 | 25.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 68 | 94 | $22,210 | $7,146 | 32.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 34 | 34 | $12,274 | $3,778 | 30.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 26 | 26 | $4,256 | $1,341 | 31.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 69 | 83 | $20,731 | $4,512 | 21.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 14 | 14 | $5,204 | $1,487 | 28.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 23 | 23 | $3,872 | $876.21 | 22.6% |
About Dr. William Emory, MD
Dr. William Emory, MD is a Pulmonary Disease healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760440028.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Emory, MD has received a total of $35,923 in payments from pharmaceutical and medical device companies, with $7,153 received in 2022. These payments were reported across 39 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($32,400).
As a Medicare-enrolled provider, Emory has provided services to 434 Medicare beneficiaries, totaling 520 services with total Medicare billing of $37,342. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location New Orleans, LA
- Active Since 05/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1760440028
Products in Payments
- CHANTIX (Drug) $25,961
- BREZTRI (Drug) $7,047
- BREZTRI AEROSPHERE (Drug) $2,576
- BEVESPI AEROSPHERE (Drug) $124.21
- TEZSPIRE (Biological) $99.12
- OFIRMEV (Drug) $22.39
- Photofrin (Drug) $17.28
- OFEV (Drug) $17.25
- MEKINIST (Drug) $15.51
- GILOTRIF (Drug) $14.15
- Nplate (Biological) $11.66
- AFINITOR (Drug) $10.35
- FASENRA (Biological) $7.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in New Orleans
Dr. Joseph Lasky, Md, MD
Pulmonary Disease — Payments: $549,698
Pulmonary Disease $549,698
Juzar Ali, Md.,Frcp., Fccp(C), MD.,FRCP., FCCP(C)
Pulmonary Disease — Payments: $233,193
Pulmonary Disease $233,193
Dr. Ramsy Abdelghani, M.d, M.D
Pulmonary Disease — Payments: $222,746
Pulmonary Disease $222,746
Dr. Nereida Parada, Md, MD
Pulmonary Disease — Payments: $17,027
Pulmonary Disease $17,027
Dr. Ross Klingsberg, M.d, M.D
Pulmonary Disease — Payments: $11,314
Pulmonary Disease $11,314
Dr. Steve Nelson, Md, MD
Pulmonary Disease — Payments: $8,881
Pulmonary Disease $8,881